Indiana University Health

Running trials

• Recruiting

  Overground Virtual Reality (VR) Gait Rehabilitation for Stroke

  NCT07676578· Indiana University· Source

• Recruiting

  The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV

  NCT07226128· Indiana University· Source

• Recruiting

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· Phase 3· Novartis Pharmaceuticals· Source

• Recruiting

  A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  NCT07284758· Phase 2· C4 Therapeutics, Inc.· Source

• Recruiting

  A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  NCT07409272· Phase 3· Astellas Pharma Global Development, Inc.· Source

• Recruiting

  A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  NCT07253285· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy

  NCT06996951· Phase 3· Indiana University· Source

• Recruiting

  Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)

  NCT06464926· Enterra Medical, Inc.· Source

• Recruiting

  Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions

  NCT06029491· RapidPulse, Inc· Source

• Recruiting

  KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

  NCT06193889· Phase 2/3· Kyverna Therapeutics· Source

• Recruiting

  Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05571059· Phase 2· Cumberland Pharmaceuticals· Source

• Active, not recruiting

  Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

  NCT05902169· Phase 3· CarThera· Source

• Recruiting

  The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

  NCT05564936· Ad scientiam· Source

• Recruiting

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  NCT06128629· Phase 3· Intellia Therapeutics· Source

• Active, not recruiting

  The BD Liverty™ TIPS Stent Graft Study

  NCT05711316· C. R. Bard· Source

• Recruiting

  I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms

  NCT05733520· Indiana University· Source

• Recruiting

  A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

  NCT05462106· Phase 1/2· AC Immune SA· Source

• Recruiting

  RA-PRO PRAGMATIC TRIAL

  NCT04692493· Phase 3· University of Alabama at Birmingham· Source

• Recruiting

  Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  NCT04054310· Perspectum· Source

• Active, not recruiting

  HEALEY ALS Platform Trial - Master Protocol

  NCT04297683· Phase 2/3· Merit E. Cudkowicz, MD· Source

• Recruiting

  ATrial Tachycardia PAcing Therapy in Congenital Heart

  NCT03209583· Ian Law· Source

• Active, not recruiting

  RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers

  NCT02818972· Bolton Medical· Source

• Recruiting

  Pulmonary Hypertension Association Registry

  NCT04071327· Pulmonary Hypertension Association, Inc.· Source

• Active, not recruiting

  Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

  NCT02181257· Phase 3· Washington University School of Medicine· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis2 recruiting
• Myasthenia gravis2 recruiting
• Stroke2 recruiting
• Alzheimer disease1 recruiting
• Congenital heart disease1 recruiting
• Cystic fibrosis1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Heart failure1 recruiting
• High blood pressure1 recruiting
• HIV1 recruiting
• Huntington's disease1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Multiple myeloma1 recruiting
• Obesity1 recruiting
• Pancreatic cancer1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Rheumatoid arthritis1 recruiting

Closed trials

• Withdrawn

  Virtual Communication in the Hospital: Impact on Patients and Surrogates

  NCT05395039· Indiana University· Source

• Withdrawn

  Activities of Daily Living (ADL) Virtual Reality (VR) for Acquired Brain Injury (ABI) Upper-Limb Rehabilitation

  NCT07026630· Indiana University· Source

• Completed

  A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

  NCT06785012· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  Access BNP Clinical Enrollment Study

  NCT06624293· Beckman Coulter, Inc.· Source

• Completed

  RNS System NAUTILUS Study

  NCT05147571· NeuroPace· Source

• Completed

  Reducing Risk of Dementia Through Deprescribing

  NCT04270474· Indiana University· Source

• Completed

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· Phase 3· Ionis Pharmaceuticals, Inc.· Source

• Completed

  Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease

  NCT04121858· Indiana University· Source

• Completed

  Decisions About Cancer Screening in Alzheimer's Disease

  NCT03282097· Indiana University· Source